GMP guidelines focus on preventing contamination by controlling the production environment, equipment, and processes. Maintaining and cleaning the facility and infrastructure is essential because it directly protects product safety and quality—clean floors, walls, drains, proper waste handling, and well-maintained equipment all reduce the risk of contamination and cross-contact. Regular cleaning, sanitation, and preventative maintenance ensure the site remains sanitary, compliant with standards, and capable of producing consistent, safe products. The other options relate to business activities outside the production environment—marketing, financial auditing, and customer support—so they don’t address the control of cleanliness and maintenance that GMP emphasizes.

Sanitation verification is proven through direct, objective checks of cleanliness after cleaning. Swab tests and ATP monitoring provide this kind of evidence. Swab tests collect samples from surfaces and test for remaining microorganisms or residues, showing whether contamination was left behind. ATP monitoring gives a rapid readout of organic matter on a surface—the presence of adenosine triphosphate indicates residues from food, microbes, or soils; a low ATP result after cleaning suggests surfaces are clean and the sanitation steps worked. Together, they offer concrete proof that cleaning procedures are effective on the actual equipment and surfaces. Training records show what the team has learned, but don’t prove that cleaning was successful. Customer feedback is subjective and can reflect perceptions rather than actual cleanliness. Production yield data relates to output performance and can be influenced by many factors beyond sanitation.

Contingency plans for monitoring devices exist to keep control of critical limits even when equipment stops working. They specify what to do if a device fails: use a backup device, perform manual checks with validated methods, verify results with an independent measurement, recalibrate when possible, document the deviation, and resume normal monitoring once the device is repaired. This approach helps maintain product safety and regulatory compliance by ensuring monitoring continues and corrective actions can be taken promptly. It’s not about replacing devices on a set schedule, nor about making failures impossible, nor is its primary purpose staff training (though training is important as part of the overall program).

A robust change control process ensures that any proposed modification is carefully evaluated for its potential impact on product safety, quality, and regulatory compliance, and that it is properly documented and approved before implementation. By conducting a risk assessment, the team identifies which quality attributes or process parameters could be affected and determines whether additional testing, validation, or requalification is needed. All changes are recorded with clear rationale, responsibilities, and evidence, providing traceability and accountability for audits and regulatory reviews. This approach prevents unintended consequences from changes, supports consistent product quality, and enables safe, approved improvements rather than ad hoc alterations. Options that suggest blocking all changes, outsourcing quality decisions, or speeding production without checks miss the purpose of controlled, informed modification and patient safety.